US · USD
BIIB
Biogen Inc
- Day's range
- $219.81 – $224.08
- Day's volume
- $170.2M
- 52-week range
- $142.26 – $228.69
Follow BIIB in the Fuolio
See how BIIB weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountBIIB in numbers
- Market cap
- $32.5B
- P/E
- 23.66
- Dividend yield (12m)
- 0.00%
BIIB trades at 23.66 times its earnings of the last 12 months.
BIIB price history
BIIB risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +20.75% | -6.07% | -6.73% |
| Volatility (annualized) | 17.39% | 23.69% | 27.34% |
| Largest drawdown | -6.07% | -53.21% | -60.32% |
| Positive months | 7/12 | 16/36 | 25/60 |
How much did investing in BIIB return?
$1,000.00 invested on 11/01/2021 would be worth $932.72 today.
- Value today in BIIB
- $932.72
- Return over the period
- -6.73%
- Return per year
- -1.41%
- In the S&P 500
- $1,690.98
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
BIIB fundamentals
Valuation
- P/E23.66
- P/B—
- EV/EBITDA—
- EV/EBIT—
- EV/Revenue3.90
- P/EBIT—
- P/S3.27
- P/OCF12.53
- P/FCF13.40
- Earnings yield—
- PEG ratio—
- Earnings per share$9.29
- Book value per share—
Debt
- Net debt$6.3B
- Net debt/EBITDA—
- Net debt/Equity—
- Debt/Equity—
- Current ratio3.06
- Quick ratio2.41
- Cash ratio—
Efficiency
- Gross margin75.49%
- EBITDA margin—
- Operating margin—
- Net margin13.81%
- Asset turnover0.34
Profitability
- ROE—
- ROA4.65%
- ROIC—
- Payout0.00%
Growth
- Revenue CAGR (5 years)-4.64%
- Earnings CAGR (5 years)-14.55%
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
BIIB's indicators by year
Multiples at each year's closing price; margins and returns from that year's statements.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | 19.98 | 13.72 | 32.40 | 13.13 | 22.66 | 9.32 | 8.77 | 13.36 |
| P/B | — | — | 2.54 | 2.99 | 3.24 | 3.49 | 3.87 | 4.54 |
| EV/EBITDA | — | — | — | — | 12.48 | 8.93 | 7.09 | 9.77 |
| Earnings per share | $8.81 | $11.15 | $7.99 | $21.09 | $10.59 | $26.26 | $33.83 | $22.52 |
| Book value per share | — | — | $101.81 | $92.73 | $74.14 | $70.24 | $76.66 | $66.29 |
| ROE | — | — | 7.84% | 22.74% | 14.28% | 37.39% | 44.13% | 33.98% |
| ROIC | — | — | — | — | 16.05% | 20.17% | 39.62% | 25.16% |
| Gross margin | 75.69% | 76.12% | 74.24% | 77.61% | 80.79% | 86.57% | 86.40% | 86.50% |
| EBITDA margin | — | — | — | — | 30.31% | 37.24% | 52.21% | 48.61% |
| Net margin | 13.07% | 16.87% | 11.80% | 29.95% | 14.17% | 29.76% | 40.96% | 32.93% |
| Net debt/EBITDA | — | — | — | — | 1.88 | 1.48 | 0.21 | 0.72 |
BIIB's financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | $9.9B | $9.7B | $9.8B | $10.2B | $11B | $13.4B |
| Cost of revenue | -$2.4B | -$2.3B | -$2.5B | -$2.3B | -$2.1B | -$1.8B |
| Gross profit | $7.5B | $7.4B | $7.3B | $7.9B | $8.9B | $11.6B |
| EBITDA | — | — | — | — | $3.3B | $5B |
| EBIT | — | — | — | — | $2.8B | $4.6B |
| Financial result | -$305.6M | -$343.6M | -$315.5M | $108.2M | -$1.1B | $497.4M |
| Income before tax | $1.6B | $1.9B | $1.3B | $3.6B | $1.7B | $5B |
| Income tax | -$263.6M | -$273.8M | -$135.3M | -$632.8M | -$52.5M | -$992.3M |
| Net income | $1.3B | $1.6B | $1.2B | $3B | $1.6B | $4B |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does BIIB pay dividends?
BIIB has no distributions on record.
About Biogen
- Sector
- Manufacturing
Questions about BIIB
How much is BIIB today?
BIIB is at $219.88 (-1.32% on the day), last traded on 10/02/2026.
How much did BIIB return in 12 months?
BIIB returned 20.75% in 12 months, with annualized volatility of 17.39% and a largest drawdown of -6.07%.